A) It occurs at the growing end of bone B) Growth continues after skeletal maturity C) It is covered by cartilaginous cap D) Malignant transfonnation may occur Answer (Select an option above to get the answer):
A) Abdomino perineal resection B) Primary radiotherapy C) Combined radio- and chemotherapy D) Neoadjuvant chemotherapy and local excision Answer (Select an option above to get the answer):
(Single Best Answer) Question 203: Which one of the following is the most significant risk factor for development of gastric carcinoma ?
A) Paneth cell metaplasia B) Pyloric metaplasia C) Intestinal metaplasia D) Ciliated metaplasia Answer (Select an option above to get the answer):
(Single Best Answer) Question 204: Which of the following is the most common presenting symptom of non-cirrhotic portal hypertension ?
A) Chronic liver failure B) Ascites C) Upper gastrointestinal bleeding D) Encephalopathy Answer (Select an option above to get the answer):
A) It is an intravenous anesthetic B) It precipitates coronary insufficiency C) It inhibits cortisol synthesis D) It causes pain at site of injection Answer (Select an option above to get the answer):
A) Binds to both GABAA and GABAB receptors B) They have active metabolites C) Decreases nocturnal gastric secretion in human being D) Extensively metabolized by CYP enzymes Answer (Select an option above to get the answer):
A) It is a prodrug B) It is a selective uncompetitive and reversible inhibitor of inosine monophosphate dehydrogenase C) It also inhibits calcineurin D) Selectively inhibits lymphocyte proliferation Answer (Select an option above to get the answer):